Cargando…
m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis
Radiotherapy is a valid treatment for nasopharyngeal carcinoma (NPC), and radioresistance is the main cause of local NPC treatment failure. However, the underlying mechanisms and valuable markers of radioresistance for NPC remain have not been established. In this study, we observed that the m6A mRN...
Autores principales: | Huang, Wei-Mei, Li, Zhi-Xun, Wu, Ying-Hui, Shi, Zhi-Ling, Mi, Jing-Lin, Hu, Kai, Wang, Ren-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646990/ https://www.ncbi.nlm.nih.gov/pubmed/36343416 http://dx.doi.org/10.1016/j.tranon.2022.101576 |
Ejemplares similares
-
m6A demethylase FTO and osteoporosis: potential therapeutic interventions
por: Huang, Mei, et al.
Publicado: (2023) -
Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021) -
Targeting the RNA demethylase FTO for cancer therapy
por: Zhou, Lin-Lin, et al.
Publicado: (2021) -
m(6)A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury
por: Ke, Wei-Liang, et al.
Publicado: (2022) -
The role of m(6)A demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse
por: Zhang, Zhi-Wei, et al.
Publicado: (2023)